Sep 3 |
Illumina avoids fine for Grail purchase in European court victory
|
Sep 3 |
EU court backs Illumina and dismisses challenge over Grail acquisition
|
Sep 3 |
Illumina wins legal battle over Grail deal in EU; avoids €432M fine
|
Sep 3 |
Europe’s Top Court Rebukes Competition Regulator, Curbing Powers
|
Sep 3 |
European Court of Justice rules in favor of Illumina in jurisdictional appeal
|
Sep 3 |
Illumina wins Grail battle in blow to EU merger power
|
Aug 29 |
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
|
Aug 29 |
The Zacks Analyst Blog Highlights DaVita and Illumina
|
Aug 28 |
ILMN's TSO Comprehensive IVD Test Secures FDA Approval as CDx
|
Aug 28 |
Illumina upgraded, Fiserv initiated: Wall Street's top analyst calls
|